Abiopharma

🔍 Sweetnam Jordan Douglas Bradley (Executive)

Company: EBAY INC (EBAY)

Report Date: 2026-03-15

Detailed Transactions and Holdings:

• Acquired 3,611 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 9,354.00 | transaction_form_type: 4
• Acquired 101,112 shares of Common Stock (Direct)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 110,466.00 | transaction_form_type: 4
• Sold 1,881 shares of Common Stock at $91.34 per share (Direct)
  Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 108,585.00 | transaction_form_type: 4
• Sold 52,659 shares of Common Stock at $91.34 per share (Direct)
  Date: 2026-03-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 55,926.00 | transaction_form_type: 4
• Sold 3,611 shares of Restricted Stock Units -1 (Derivative)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 14,445.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
• Acquired 101,112 shares of Restricted Stock Units -4 (Derivative)
  Date: 2026-03-15 | Code: A | equity_swap_involved: 0 | shares_owned_after: 101,112.00 | transaction_form_type: 4 | Footnotes: F1, F4, F3
• Sold 101,112 shares of Restricted Stock Units -4 (Derivative)
  Date: 2026-03-15 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F4, F3

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
• F2: The reporting person received restricted stock units, 1/16th of which vested on 6/15/23, and an additional 1/16th of which vests each quarter thereafter. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.
• F3: Not Applicable.
• F4: The reporting person was granted 101,112 restricted stock units as a result of the company's achievement of certain performance criteria during the period from 1/1/23 to 3/15/26, with 100% of the shares vesting on 3/15/26. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.